Indivior plunges after losing opioid addiction patent case

LONDON (Reuters) - Britain's Indivior is set to face cheap competition to its opioid addiction treatment Suboxone Film after losing a patent protection case, sending its shares more than 20 percent lower on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

ConclusionThe report aims at pointing out the possibility of undergoing this kind of surgery not only in case of pulmonary mass (on which the previous literature has focused) but also when mediastinum lesions occur, as in our case.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Conclusions: Pretreatment characteristics differentially predict treatment response for heroin and cocaine use. Similar research in diverse patient groups may aid in the development of personalized treatment combining biologic treatment with targeted psychosocial interventions. PMID: 31315479 [PubMed - as supplied by publisher]
Source: Substance Use and Misuse - Category: Addiction Tags: Subst Use Misuse Source Type: research
In this study, we investigate the involvement of PFC DRD2 and DAT in ketamine addiction effects after ketamine administration for 10 weeks in nonhuman primates. To this end, after administering ketamine to rhesus monkeys for 10 weeks, we assessed changes in body weight and behavior. Additionally, neuronal changes in the PFC were examined by hematoxylin and eosin (HE) staining, the DRD2 and DAT mRNA and protein expression levels in the PFC were determined by real-time PCR and Western blot analysis, respectively. After 10-week ketamine administration, the assessment of the manifestations of toxicity in rhesus monkeys reveale...
Source: Neuroscience - Category: Neuroscience Source Type: research
This week’s Psychology Around the Net has the latest on a new virtual reality therapy trial for people diagnosed with serious mental illnesses, how people with mental health disorders are helping amend their descriptions in diagnostic guidelines, the issues that stop you from setting boundaries and how you can overcome those issues, and more. People With Mental Health Disorders Amend the Descriptions: What would happen if input from people who actually deal with mental health disorders on a daily basis was taken into consideration when it comes to the diagnostic guidelines describing said disorders? A new study set ...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Psychology Around the Net Addiction Cannabis cannabis dependency cannabis treatment Loneliness Nhs Procrastination Productivity Psychosis Setting Boundaries Shame virtual reality Source Type: blogs
The objective of this document is to offer clinical guidance for screening, diagnosis and management of co-occurring betel quid chewing among persons with Diabetes Mellitus (DM). The document aims to provide education and guidance to clinicians engaged in care and management of persons with DM, and improve access to treatment for co-occurring betel quid chewing among persons with DM. The current recommendation grades are based on published evidence, and categorized as strong, intermediate, weak and no evidence. The strength of these recommendations is based on the level of evidence. PMID: 31315339 [PubMed - in process]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
The rapid rise of electronic cigarette (e-cigarette) use among youth subverts our traditional understanding of adolescent tobacco use, the natural history of nicotine addiction through the use of combustible tobacco, and the implications of dual use of e-cigarettes and combustible cigarettes. The ramifications of initiating tobacco use with nicotine vapor in adolescence are largely unknown, as are the appropriate classifications of adolescent tobacco users in the e-cigarette era or means to identify the populations most likely to benefit from nicotine cessation strategies.
Source: Journal of Adolescent Health - Category: Child Development Authors: Tags: Editorial Source Type: research
We examined factors associated with reporting sex with men among men who inject drugs in Vancouver, Canada. Data were drawn from three open prospective cohorts of people who use drugs between 2005 and 2014. Generalized estimating equations were used to identify factors associated with reporting non-transactional sex with men (MSM) in the previous 6  months. Of 1663 men who used injection drugs, 225 (13.5%) were MSM over the study period. Sex with men was independently associated with younger age [Adjusted Odds Ratio (AOR) = 0.96], childhood sexual abuse (AOR = 2.65), sex work (AOR =&...
Source: AIDS and Behavior - Category: Infectious Diseases Source Type: research
AbstractPurpose of ReviewNon-invasive neuromodulation as a potential therapeutic target in addiction treatment is a fast-growing, but nascent research field. With gambling disorder as the first behavioral addiction, the goal of this review is to provide an overview of the current state-of-the-art of neuromodulation in substance use disorders and gambling disorder.Recent FindingsOnly a few neuromodulation studies in gambling disorder are present, most of these are single-session studies. Effects of rTMS on craving have been described, but large placebo effects are also present, indicating a need for larger, blinded, multipl...
Source: Current Addiction Reports - Category: Addiction Source Type: research
Conclusions: Effective MMA strategies have paved the way for OFA approaches to postoperative pain management, with goals to reduce opioid prescriptions, improve patient recovery, and reduce overall healthcare resource utilization and costs. However, institution-wide deployment and adoption of OFA is still in early stages and will require personalization and better management of patient expectations. PMID: 31315466 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
One of MedicaSafe’s primary goals is to develop products for high-risk medication management. So it makes sense for the New York-based company to focus on opioid addiction, which claims the lives of more than 130 people every day in the U.S. (According to the U.S. Department of Health and Human Services). The New York-based company recently received $1 million Small Business Innovation Research grant from the National Institute of Health, with a specific focus on opioid use disorder (OUD). The funding will support a clinical trial to examine the effect of MedicaSafe’s drug-device combina...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Digital Health Source Type: news
More News: Addiction | Health | Suboxone | UK Health